Aytu Biopharma (AYTU) Revenue (2013 - 2026)
Aytu Biopharma's Revenue was $16.11 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 6.4% from $15.14 million a year earlier and up 29.8% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Revenue (2013 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Revenue at Aytu Biopharma came in at $57.57 million, down 13.3% from FY2025.
- Revenue shows a five-year compound annual growth rate of -2.6% (FY2021 to FY2026).
- In earlier fiscal years, Revenue was $66.38 million in FY2025 (+1.8%), $65.18 million in FY2024 (-39.3%), $107.4 million in FY2023 (+11.1%) and $96.67 million in FY2022 (+47.3%).
- The fiscal Q4 2026 figure marks the highest quarterly Revenue since fiscal Q3 2025.
- Compared with a year earlier, Revenue was higher in three of the last eight quarters, with an average decline of 4.3%.
- The best year-over-year quarter for Revenue over five years was fiscal Q3 2022 (growth of 79.5%); the worst was fiscal Q4 2024 (a decline of 52.5%).
- Per Business Quant data, AYTU's Revenue in the three fiscal quarters before Q4 2026 was $12.41 million (Q3 2026), $15.17 million (Q2 2026) and $13.89 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Aytu Biopharma | 23.25 Mn | -92.42 Mn | 10.41 Mn | 16.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.11 Mn |
| Mar 31, 2026 | 12.41 Mn |
| Dec 31, 2025 | 15.17 Mn |
| Sep 30, 2025 | 13.89 Mn |
| Jun 30, 2025 | 15.14 Mn |
| Mar 31, 2025 | 18.45 Mn |
| Dec 31, 2024 | 16.22 Mn |
| Sep 30, 2024 | 16.57 Mn |
| Jun 30, 2024 | 14.59 Mn |
| Mar 31, 2024 | 14.03 Mn |
| Dec 31, 2023 | 18.75 Mn |
| Sep 30, 2023 | 17.82 Mn |
| Jun 30, 2023 | 30.73 Mn |
| Mar 31, 2023 | 22.73 Mn |
| Dec 31, 2022 | 26.28 Mn |
| Sep 30, 2022 | 27.66 Mn |
| Jun 30, 2022 | 27.45 Mn |
| Mar 31, 2022 | 24.20 Mn |
| Dec 31, 2021 | 23.13 Mn |
| Sep 30, 2021 | 21.90 Mn |
API Access
Aytu Biopharma Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();